Mutant reverse transcriptase
US9932567B1 · kind B1 · utility
41Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2017 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Jan 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/26004
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A mutant MMLV reverse transcriptase that may have an improvement in one or more properties is provided. For example, the present reverse transcriptase is believed to be more efficient relative to other commercially available MMLV reverse transcriptase variants, particularly for templates with a higher GC content.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.